5-Amino-1MQ and Tirzepatide Interaction

Compatible
Researched 90% confidence

5-Amino-1MQ and Tirzepatide have a compatible interaction with 90% confidence. NNMT inhibition may complement GLP-1 effects for metabolic optimization. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

5-Amino-1MQ

NNMT Inhibitor | Longevity & Metabolic Enhancement

Inhibits NNMT enzyme systemically, preventing NAD+ degradation and maintaining elevated cellular NAD+ levels to support mitochondrial function and metabolic processes..

Half-life: 4-7 hours (3.8h IV, 6.9h oral) Typical dose: 50-100mg oral or 150-500mcg SubQ longevity, metabolic, weight loss
teratogenic
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (5-Amino-1MQ, Tirzepatide). Monitor accordingly.

Frequently Asked Questions

Can I take 5-Amino-1MQ with Tirzepatide?

Yes, 5-Amino-1MQ and Tirzepatide can generally be taken together. NNMT inhibition may complement GLP-1 effects for metabolic optimization.

Is 5-Amino-1MQ and Tirzepatide safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between 5-Amino-1MQ and Tirzepatide?

NNMT inhibition may complement GLP-1 effects for metabolic optimization. This assessment has 90% confidence and is based on documented research data.

How should I time 5-Amino-1MQ and Tirzepatide?

5-Amino-1MQ has a half-life of 4-7 hours (3.8h IV, 6.9h oral) and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: 5-Amino-1MQ vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.